Moderne shares act higher on Friday: what’s going on? – Moderna (Nasdaq: mrna)

Modern, Inc. Mrna Shares act higher on Friday after the company has received the approval of the Health Canada for the updated COVID-19 vaccine.

What to know: Health Canada authorized Moderna’s updated Spikevax Covid-19 MRNA vaccine focused on the SARS-COV-2 LP.8.1 variant for individuals six months and older. The company said it is on its way to deliver the vaccine on time for the vaccination season 2025-2026.

All pre-filled spraying doses for the Canadian market will be manufactured in its own country for the first time, with the production of medicines in Moderna in the new facility of Moderna in Laval, Quebec and Fill-Finish Operations completed by Novocol Pharma in Cambridge, Ontario. The doses made in Canada are expected to be available this fall.

“This approval is a milestone of the regulations and proof of the growing leadership of Canada in biomanufacturing and resilience of public health,” said Stéphane BanlCEO of Modern.

The vaccine has already been approved by supervisors in Europe, Japan, Switzerland and other countries, with additional applications that are revised worldwide.

See also: 10 shares that rock after Powell’s Dovish Shift

Mrna -price promotion: At the time of writing, Moderna shares act 4.23% higher at $ 27.33, according to data from Petrol.

Image via Shutterstock